Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels

Background: The optimal therapeutic strategy for coronary intervention in very small coronary vessels (<2.5 mm.) remains controversial and challenging. Objective: The aim of this study is to assess the 12 months outcome of scoring balloon (SB) versus drug-eluting balloon (DEB) in very small (<...

Full description

Bibliographic Details
Main Authors: Yasser Gaber Metwally, Khaled Y Elnady
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Indian College of Cardiology
Subjects:
Online Access:http://www.joicc.org/article.asp?issn=1561-8811;year=2021;volume=11;issue=3;spage=127;epage=132;aulast=Metwally
_version_ 1797321548227411968
author Yasser Gaber Metwally
Khaled Y Elnady
author_facet Yasser Gaber Metwally
Khaled Y Elnady
author_sort Yasser Gaber Metwally
collection DOAJ
description Background: The optimal therapeutic strategy for coronary intervention in very small coronary vessels (<2.5 mm.) remains controversial and challenging. Objective: The aim of this study is to assess the 12 months outcome of scoring balloon (SB) versus drug-eluting balloon (DEB) in very small (<2.5 mm) coronary interventions. Patients and Methods: Seventy-seven patients referred for coronary intervention with reference vessel diameter <2.5 mm were assigned to either SB or DEB. The primary endpoint was target vessel revascularization (TVR) at 12 months follow-up. Results: Out of 77 patients enrolled, 37.7% were assigned to SB, while 62.3% were assigned to DEB. Sever dissection rate was significantly higher among the DEB group (0% vs. 12.5%, P = 0.048); while TVR rate was significantly lower among the SB group (0% vs. 12.5%, P = 0.048). Similarly, the target vessel-related myocardial infarction rate was significantly lower among the SB group (0% vs. 12.5%, P = 0.048). On the other hand, there were no significant differences in the rates of deaths or restenosis between the two groups. Conclusion and Recommendations: SB is superior to the DEB with better both safety and efficacy for coronary intervention in very small coronary vessels (<2.5 mm). Larger scaled prospective multicenter randomized trials are needed for confirming our favorable results of using SB for coronary intervention in very small coronary vessels <2.5 mm.
first_indexed 2024-03-08T05:00:10Z
format Article
id doaj.art-31ad7da2a671493dbba397800e41b666
institution Directory Open Access Journal
issn 1561-8811
2213-3615
language English
last_indexed 2024-03-08T05:00:10Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Indian College of Cardiology
spelling doaj.art-31ad7da2a671493dbba397800e41b6662024-02-07T12:56:13ZengWolters Kluwer Medknow PublicationsJournal of Indian College of Cardiology1561-88112213-36152021-01-0111312713210.4103/JICC.JICC_59_20Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vesselsYasser Gaber MetwallyKhaled Y ElnadyBackground: The optimal therapeutic strategy for coronary intervention in very small coronary vessels (<2.5 mm.) remains controversial and challenging. Objective: The aim of this study is to assess the 12 months outcome of scoring balloon (SB) versus drug-eluting balloon (DEB) in very small (<2.5 mm) coronary interventions. Patients and Methods: Seventy-seven patients referred for coronary intervention with reference vessel diameter <2.5 mm were assigned to either SB or DEB. The primary endpoint was target vessel revascularization (TVR) at 12 months follow-up. Results: Out of 77 patients enrolled, 37.7% were assigned to SB, while 62.3% were assigned to DEB. Sever dissection rate was significantly higher among the DEB group (0% vs. 12.5%, P = 0.048); while TVR rate was significantly lower among the SB group (0% vs. 12.5%, P = 0.048). Similarly, the target vessel-related myocardial infarction rate was significantly lower among the SB group (0% vs. 12.5%, P = 0.048). On the other hand, there were no significant differences in the rates of deaths or restenosis between the two groups. Conclusion and Recommendations: SB is superior to the DEB with better both safety and efficacy for coronary intervention in very small coronary vessels (<2.5 mm). Larger scaled prospective multicenter randomized trials are needed for confirming our favorable results of using SB for coronary intervention in very small coronary vessels <2.5 mm.http://www.joicc.org/article.asp?issn=1561-8811;year=2021;volume=11;issue=3;spage=127;epage=132;aulast=Metwallyelutingscoring balloonsmall coronary
spellingShingle Yasser Gaber Metwally
Khaled Y Elnady
Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
Journal of Indian College of Cardiology
eluting
scoring balloon
small coronary
title Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
title_full Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
title_fullStr Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
title_full_unstemmed Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
title_short Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
title_sort scoring balloon versus drug eluting balloon in coronary intervention for very small coronary vessels
topic eluting
scoring balloon
small coronary
url http://www.joicc.org/article.asp?issn=1561-8811;year=2021;volume=11;issue=3;spage=127;epage=132;aulast=Metwally
work_keys_str_mv AT yassergabermetwally scoringballoonversusdrugelutingballoonincoronaryinterventionforverysmallcoronaryvessels
AT khaledyelnady scoringballoonversusdrugelutingballoonincoronaryinterventionforverysmallcoronaryvessels